Abstract:OBJECTIVE:To analyze the germline variations of genes RET, VHL, SDHD and SDHB in patients with pheochromocytoma and/or paraganglioma and to evaluate variations of these genes in Chinese patients.METHODS:Patients who were treated in Peking University First Hospital from September 2012 to March 2014 and diagnosed with pheochromocytoma and/or paraganglioma by pathologists were included in this study. Twelve patients were included in total, of whom 11 had pheochromocytoma, and 1 had paraganglioma. Deoxyribonucleic acid (DNA) was extracted from the leukocytes of peripheral blood of the patients. The exons 10, 11, 13-16 of the RET gene, and all exons of VHL, SDHB and SDHD genes and their nearby introns (±20 bp) were amplified with polymerase chain reactions, and the products were sent to a biotechnology company for sequencing. The sequencing results were compared with wildtype sequences of these genes to identify variations. One of the patients was diagnosed with multiple endocrine neoplasia type 2A. A family analysis was performed in his kindred, and his family members received genetic tests for the related variations.RESULTS:Three patients were found to have germline gene variations. A c.136C>T (p.R46X) variation of the SDHB gene was found in a patient with malignant pheochromocytoma. A c.1901G>A (C634Y) variation, as well as c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were found in a patient with multiple endocrine neoplasia type 2A. After a family analysis, five family members of this patient were found to have the same variations. c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene were also found in a clinical sporadic patient without evidence of malignancy. A patient with congenital single ventricle malformation and pheochromocytoma was included in this study, and no variation with clinical significance was found in the four genes of this patient.CONCLUSION:25% (3/12) patients with pheochromocytoma or paraganglioma were found to have missense or nonsense germline gene variations in this study, including the c.136C>T (p.R46X) variation of the SDHB gene, the c.1901G>A (C634Y) variation of the RET gene, and c.2071G>A (p.G691S) and c.2712C>G (p.S904S) variations of the RET gene. The former two variations have already been confirmed to be pathogenic. The existence of these variations in Chinese patients with pheochromocytoma and/or paraganglioma was validated in this study, which supports the conclusion that genetic testing is necessary to be generally performed in patients with pheochromocytoma and/or paraganglioma.

Overexpression Of Erbb-2 Was More Frequently Detected In Malignant Than Benign Pheochromocytomas By Multiplex Ligation-Dependent Probe Amplification And Immunohistochemistry

Gene expression profiles of phaeochromocytomas with ERBB2 overexpression reveal a new molecular mechanism tumourigenicity.

ERBB-2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas.

The expression and significance of ERBB2、p-ERK、p-AKT、p-JNK in pheochromocytomas

Predictive Factors for Malignant Pheochromocytoma: Analysis of 136 Patients.

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

The Expression and Significance of Tumor Marker in Malignant Pheochromocytoma

Expression of CXCR4 in pheochromocytomas and its significance

Significance of genes encoding peptide processing factors In differential diagnosis of benign and malignant pheochromocytomas

Expression and Diagnostic Relevance of Heat Shock Protein 90 and Signal Transducer and Activator of Transcription 3 in Malignant Pheochromocytoma

Molecular and Clinicopathological Characteristics of ERBB2 Gene Fusions in 32,131 Chinese Patients with Solid Tumors.

Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas

Bioinformatic Analysis of Differentially Expressed Genes As Prognostic Markers in Pheochromocytoma and Paraganglioma Tumors.

The gene expression profiling of sporadic pheochromocytoma and novel full-length cDNAs cloning

[Germline Gene Testing of the RET, VHL, SDHD and SDHB Genes in Patients with Pheochromocytoma/paraganglioma].

Expression and significance of VEGF and NSE in benign and malignant pheochromocytoma

Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2

Diagnosis of malignant chromaffin-cell tumor

Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas

The Expression Profile and Heterogeneity Analysis of ERG in 633 Consecutive Prostate Cancers from a Single Center

Expressionprofile of HSP90 Between Benign and Malignant Pheochromocytoma